January 30, 2012

Trius Therapeutics, Inc. Announces Exercise
in Full of Underwriters' Option to Purchase Additional Shares for Common Stock Offering

January 26, 2012

Trius Therapeutics, Inc. Prices Public Offering
of Common Stock

January 25, 2012

Trius Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

October, 2011

Genetic Environment and Stability
of cfr in MRSA CM05, Locke et al.

September, 2011

In Vitro Activity of Tedizolid (TR-700) Against Linezolid-Resistant Staphylococci, Rodriguez-Avial et al.